Related Experiment Video
Updated: Feb 16, 2026

05:26
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
2.1K
P-glycoprotein expression in oral lichen planus
Abhishek Jana1, Jimcy Thomas2, Pratiti Ghosh3
1PMS College of Dental Science & Research, Department of Physiology, Kerala, India.
Brazilian Oral Research
|December 22, 2017
Summary
Oral lichen planus (OLP) shows overexpression of the multidrug resistance (mdr1) gene and its protein, p-glycoprotein. This finding is more pronounced in the aggressive erosive form, suggesting increased malignant potential and chemoresistance.
Area of Science:
- Oral pathology
- Molecular biology
- Oncology
Background:
- Oral lichen planus (OLP) is an inflammatory condition with malignant potential.
- The multidrug resistance (mdr1) gene and its protein product, p-glycoprotein, are associated with stress and cancer.
- OLP presents as asymptomatic reticular or aggressive erosive forms.
Purpose of the Study:
- To investigate p-glycoprotein expression in OLP.
- To compare expression levels in reticular OLP (untreated and antifungal-treated) and erosive OLP (untreated and corticosteroid-treated).
Main Methods:
- Semi-quantitative reverse transcriptase polymerase chain reaction (SQ-RTPCR) for mdr1 mRNA.
- Enzyme-linked immunosorbent assay (ELISA) for p-glycoprotein.
- Analysis of biopsy tissue samples from OLP patients and healthy individuals.
Main Results:
- mdr1 mRNA and p-glycoprotein are overexpressed in OLP compared to healthy controls.
- Overexpression is significantly higher in erosive OLP than reticular OLP.
- Corticosteroid-treated erosive OLP showed higher expression than untreated erosive OLP.
- Expression levels correlate with disease severity.
Conclusions:
- OLP exhibits overexpression of mdr1 and p-glycoprotein, indicating potential for multidrug resistance.
- The erosive form of OLP has a higher risk associated with multidrug resistance.
- Findings suggest a link between p-glycoprotein expression, OLP severity, and malignant potential.

